Search results for "Carcinogen"

showing 10 items of 6867 documents

Prevalence of Cardiac Disease in Breast Cancer Patients at Time of Diagnosis Compared to the General Female Population in Germany.

2018

<b><i>Background:</i></b> Advances in oncological therapy have significantly improved breast cancer survival; therefore comorbid conditions are becoming more relevant. We investigated the prevalence of prior cardiovascular diseases and risk factors in patients with breast cancer compared to those in the general female population in Germany. <b><i>Methods:</i></b> The PASSOS heart study is a retrospective multicenter cohort study on cardiac late effects in breast cancer patients treated between 1998 and 2008. We analyzed the frequencies of cardiac diseases and cardiovascular risk factors in patients from this cohort as documented in anesthesia …

medicine.medical_specialtybusiness.industryBreast surgerymedicine.medical_treatmentDiseasemedicine.diseaseAngina03 medical and health sciences0302 clinical medicineBreast cancerOncology030220 oncology & carcinogenesisInternal medicineCohortMedicineSurgery030212 general & internal medicineMyocardial infarctionbusinessStrokeCohort studyResearch ArticleBreast care (Basel, Switzerland)
researchProduct

Randomized Comparison of Sequential High-Dose Cytosine Arabinoside and Idarubicin (S-HAI) with or without Chemo-Modulation by Fludarabine in Refracto…

2001

In order to assess the value of the addition of fludarabine as a chemo-modulator to a high-dose AraC based salvage regimen for patients with refractory and relapsed acute myeloid leukemia the German AML Cooperative Group initiated a prospective randomized comparison between fludarabine q 12 hours on days 1,2,8, and 9 in addition to the S-HAI regimen, consisting of high-dose AraC q 12 hours on days 1, 2, 8, and 9 and idarubicin on days 3,4,10, and 11, as compared with S-HAI alone. Ninety-one patients have entered the ongoing study, 66 of whom are fully evaluable at the present time (median age 54 years, range 20-75). Twentyfive patients had refractory disease or early relapses, 39 patients h…

medicine.medical_specialtybusiness.industryCD34Myeloid leukemiaNeutropeniamedicine.diseaseGastroenterology3. Good healthFludarabine03 medical and health sciencesRegimen0302 clinical medicineRefractory030220 oncology & carcinogenesisInternal medicineToxicityMedicineIdarubicinbusiness030215 immunologymedicine.drug
researchProduct

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

2017

WOS: 000458034100002

medicine.medical_specialtybusiness.industryCancerAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseMean differenceCancer antigen03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMeta-analysisInternal medicineJournal ArticleMedicineSinus rhythmIn patientCardiology and Cardiovascular MedicineProspective cohort studybusinessOriginal ResearchHeart Asia
researchProduct

Hepatocellular carcinoma: one world, one cancer—different guidelines?

2018

Hepatocellular carcinoma (HCC) is a healthcare challenge in virtually all parts of the world. Therefore, it is no wonder that different guidelines have been developed reflecting expert consensus on the management of HCC in different regions, namely guidelines from the American Association for the Study of Liver Diseases (AASLD) for the USA (1,2), the Asian Pacific Association for the Study of the Liver (APASL) for the Asia-Pacific region (3), the European Association for the Study of the Liver (EASL) for Europe (4), and the Japan Society of Hepatology (JSH) for Japan (5,6). In 2018 an update of the EASL clinical practice guidelines (CPG) will appear.

medicine.medical_specialtybusiness.industryCancerExpert consensusHepatologymedicine.diseaseClinical Practice03 medical and health sciences0302 clinical medicineEditorial030220 oncology & carcinogenesisHepatocellular carcinomaFamily medicineInternal medicinemedicine030211 gastroenterology & hepatologybusiness
researchProduct

Reply

2017

medicine.medical_specialtybusiness.industryCancerGold standard (test)030230 surgerymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineLymphedema030220 oncology & carcinogenesisLymph flowmedicineSurgeryRadiologybusinessReliability (statistics)Plastic and Reconstructive Surgery
researchProduct

Cystic mass of the floor of the mouth

2018

Background Epidermoid and dermoid cysts in the oral cavity are relatively uncommon lesions of developmental origin. They often remain asymptomatic for years until they grow enough to interfere with speech, deglutition and less often with breathing which can pose a critical risk to the airway and require immediate surgery. Case description A case of an epidermoid cyst of the floor of the mouth affecting a 37-year-old man is presented; this lesion was surgically enucleated with an intraoral approach. Patient did well postoperatively and there was no evidence of recurrence up to 2 years of follow up. Clinical implications Floor of the mouth is a challenging site for the diagnosis of a broad va…

medicine.medical_specialtybusiness.industryCase Report030206 dentistryEpidermoid cystmedicine.disease:CIENCIAS MÉDICAS [UNESCO]AsymptomaticLesion03 medical and health sciences0302 clinical medicineSwallowingDermoid cyst030220 oncology & carcinogenesisRadiological weaponUNESCO::CIENCIAS MÉDICASmedicineotorhinolaryngologic diseasesRadiologyOral SurgeryDifferential diagnosismedicine.symptombusinessAirwayGeneral Dentistry
researchProduct

Spontaneous partial regression of low-grade mucoepidermoid carcinoma of the maxilla

2018

medicine.medical_specialtybusiness.industryCase Report030206 dentistrymedicine.diseaseMicrobiologyRegression03 medical and health sciences0302 clinical medicineInfectious DiseasesText miningMucoepidermoid carcinoma030220 oncology & carcinogenesisMaxillaMedicineParasitologyRadiologybusinessOxford Medical Case Reports
researchProduct

Course of olfaction after sinus surgery for chronic rhinosinusitis

2017

Background The influence of surgery on olfaction in patients who suffer from chronic rhinosinusitis (CRS) is still not fully understood. Most particularly, the time course of the recovery is poorly studied. Methods The prospective study describes the results of the Sniffin' Sticks identification test in 41 subjects before (V1), 2 weeks after (V2), and 6 months after (V3) endonasal sinus surgery (ESS). Influencing factors (gender, revision surgery, nasal polyposis, and initial olfactory score) on the changes of the smell testing were evaluated. Results The whole cohort showed a significant improvement in Identification scores, from 8.63 to 10.24 after 2 weeks and to 10.68 after 6 months. Pat…

medicine.medical_specialtybusiness.industryChronic rhinosinusitisGeneral MedicineOlfactionSinus surgerymedicine.diseaseGastroenterologySurgery03 medical and health sciences0302 clinical medicineQuality of life030220 oncology & carcinogenesisInternal medicineCohortmedicineNasal polypsIn patient030223 otorhinolaryngologyProspective cohort studybusinessLaryngoscope Investigative Otolaryngology
researchProduct

Predictive Factors of Health Discharge Outcomes for Colorectal Cancer Patients in a Romanian Hospital

2020

Abstract In-hospital data on colorectal cancer from Romania demonstrate differences from other European countries, especially in the mean age of patients, discharge rates and length of stay. Our study aimed to investigate possible factors that could predict the health outcomes at the discharge of colorectal cancer patients hospitalized in a Romanian county hospital. We retrospectively analysed 9009 colorectal cancer patients from a Romanian County Hospital. The model of binary logistic regression, a stationary or aggravated discharge disposition was associated with patients with age equal or higher than 60 years (p=0.002), the nonretirement status of patients (p=0.004), discharge from a sur…

medicine.medical_specialtybusiness.industryColorectal cancerRomanianGeneral Medicinemedicine.diseaselanguage.human_language03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicinemedicinelanguage030212 general & internal medicinebusinessActa Medica Transilvanica
researchProduct

Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles.

2017

Background The objectives of this study were to evaluate the methodological quality of rigorous neuropathic pain assessment tools in applicable clinical studies, and determine the performance of screening tools for identifying neuropathic pain in patients with cancer. Methods Systematic literature search identified studies reporting use of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Douleur Neuropathique en 4 (DN4) or painDETECT (PDQ) in cancer patients with a clinical diagnosis of neuropathic or not neuropathic pain. Individual patient data were requested to examine descriptor item profiles. Results Six studies recruited a total of 2301 cancer patients of which 1564 (68%) r…

medicine.medical_specialtybusiness.industryConcordanceCancermedicine.disease03 medical and health sciences0302 clinical medicineAnesthesiology and Pain MedicineSymptom profiles030220 oncology & carcinogenesisClinical diagnosisNeoplasmsNeuropathic painPhysical therapyMedicineHumansNeuralgiaScreening toolIn patientbusinessCancer pain030217 neurology & neurosurgeryPain MeasurementBritish journal of anaesthesia
researchProduct